## HIMS: Hims & Hers Health, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -6.8% below STRENGTH zone (4.0-10.0%); PEG 1.88 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($29.87)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bearish (Bullish: 0, Bearish: 0)

**1. How Hims & Hers Health Inc. Class A (HIMS) Affects Rotational Strategy Timing**
- Source: Stock Traders Daily | 20260101T011600 | Somewhat-Bearish | Relevance: 95%
- This article analyzes Hims & Hers Health Inc. (HIMS) through a rotational strategy timing lens, highlighting weak near and mid-term sentiment that could challenge a positive long-term outlook. Predictive AI models have generated distinct trading strategies, including long, breakout, and short positions, adapted for different risk profiles. The analysis further provides multi-timeframe signal analysis, showing current support and resistance levels.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $48 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 6 ($0.01M) |
| Sells | 20 ($5.64M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 67.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- JPMORGAN CHASE & CO: 16.2% (+1198.1%)
- Blackrock Inc.: 11.5% (+1.6%)
- Vanguard Group Inc: 8.9% (+4.5%)
- Capital World Invest: 8.6% (+1.2%)
- Farallon Capital Man: 4.9% (+30.8%)

### Key Risks

1. High beta (2.41) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Insider selling cluster: $5.6M in recent transactions.
3. High short interest (35.2%, 3.9 days to cover): squeeze risk or crowded bearish bet.
4. Long-term trend broken: trading 27.0% below SMA200.
5. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.88 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 26%). Insider selling cluster ($5.6M in 90 days), potential headwind. Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $7.6B |
| Beta | 2.41 |
| 52W Range | $23.97 - $72.98 |
| Short Interest | 35.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.88 |
| Forward P/E | 50.8 |
| Current P/E | 69.9 |
| YoY Growth | 37.8% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from -8.0% to -6.8% (+1.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 10.8pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.5%) - potential reversal signal. AM_20 at -7.4% indicates price below own 20MA trend. Underperforming sector by 8.4pp, stock-specific weakness. Below SMA200 (0.73x), long-term trend not supportive. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -6.82% (CS: 3) | Weak |
| RSI_14 | 37.1 | Neutral |
| MACD Histogram | -0.08 | Bearish |
| vs SMA20 | 0.926x | Below |
| vs SMA50 | 0.859x | Below |
| vs SMA200 | 0.730x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $33.41
- **Stop Loss:** $29.87 (10.6% risk)
- **Target:** $36.95 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 406
- **Position Value:** $13,564.46
- **Portfolio %:** 13.56%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-23 (Est: $0.05)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.10 | $0.06 | -41.0% |
| 2025Q2 | $0.16 | $0.17 | +3.2% |
| 2025Q1 | $0.12 | $0.20 | +65.0% |
| 2024Q4 | $0.11 | $0.11 | +0.7% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*